HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ICMAD Responds To Senate Proposal: Cosmetics Should Not Be Regulated Like Foods

This article was originally published in The Rose Sheet

Executive Summary

Small business advocate says the Senate Health Committee’s discussion draft – the Modernization of Cosmetics Regulation Act – would impose burdens on industry on par with requirements for foods. But while food products continue to pose significant risks, “no such record exists for the cosmetics industry,” the trade group asserts.

Advertisement

Related Content

ICMAD Attorney: ‘Bad’ Cosmetics Bill Won’t Get Through Senate, But Next Session Is Less Certain
Rep. Pallone’s Discussion Draft For Cosmetics Reform Closely Mirrors Reintroduced Feinstein/Collins Bill
FDA Determined To Update Cosmetics Regs After Claire’s Refuses To Recall Asbestos-Tainted Makeup
Cosmetics ‘Are Not Risk-Free’; FDA Committed to Modernizing Regs – Commish Gottlieb
116th Congress Could Test Cosmetic Industry’s Commitment To Reg Reform, Preemption Viability
FDA To Try Its Hand At Sunscreen Absorption Study, A MUsT For TEA Sponsors
Senate Health Committee Releases Cosmetics Reform Discussion Draft
Surprise Hatch Bill Lays Middle Ground For Cosmetic Regulatory Reform
Think FDA Inspections Are Painful Now? These Could Be The Good Old Days
ICMAD Clutches To House Cosmetics Bill Before Specter Of ‘Activist FDA’

Topics

Advertisement
UsernamePublicRestriction

Register

RS121529

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel